Reported 1 day ago
Eli Lilly (NYSE: LLY) has introduced the Easy Mounjaro injector pen in India as of August 13, enhancing the administration of its diabetes and weight-loss drug, Mounjaro, which was previously available only in vials since its launch in March. This timely launch coincides with increasing obesity and type 2 diabetes cases in India, creating a significant demand for such treatments, despite competition from cheaper alternatives like Novo Nordisk's Wegovy.
Source: YAHOO